Corient Private Wealth’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.79M Sell
17,585
-5,350
-23% -$912K ﹤0.01% 1170
2026
Q1
$4.17M Sell
22,935
-3,168
-12% -$629K 0.01% 921
2025
Q4
$5.66M Buy
26,103
+6,112
+31% +$1.34M 0.01% 729
2025
Q3
$5.13M Sell
19,991
-2,550
-11% -$641K 0.01% 702
2025
Q2
$5.85M Sell
22,541
-618
-3% -$157K 0.01% 658
2025
Q1
$5.64M Buy
23,159
+2,540
+12% +$638K 0.01% 657
2024
Q4
$5.26M Sell
20,619
-165
-0.8% -$44.2K 0.01% 679
2024
Q3
$6.11M Sell
20,784
-298
-1% -$84K 0.01% 693
2024
Q2
$5.11M Sell
21,082
-1,524
-7% -$364K 0.01% 705
2024
Q1
$6.05M Buy
22,606
+412
+2% +$105K 0.01% 665
2023
Q4
$5.49M Buy
22,194
+1,593
+8% +$323K 0.01% 678
2023
Q3
$3.77M Buy
20,601
+3,200
+18% +$653K 0.01% 705
2023
Q2
$4.09M Buy
17,401
+237
+1% +$49.9K 0.01% 686
2023
Q1
$3.48M Buy
17,164
+2,193
+15% +$456K 0.01% 689
2022
Q4
$2.91M Buy
+14,971
New +$2.74M 0.01% 618

Other funds holding EFX

Corient Private Wealth's EFX Position: Q2 2026 in Review

Corient Private Wealth reduced its Equifax (EFX) stake by 23% in Q2 2026, selling an estimated $912K and leaving 17,585 shares worth $2.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1170.

Corient Private Wealth first reported a position in EFX in Q4 2022 and has held it in 15 quarters since. The position peaked at $6.11M in Q3 2024. 838 funds tracked by Wall St. Rank hold EFX as of Q2 2026.

  • Corient Private Wealth held 17,585 shares of Equifax worth $2.79M as of Q2 2026.
  • Corient Private Wealth sold 5,350 Equifax shares in Q2 2026, an estimated $912K.
  • Equifax made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1170 holding.
  • Corient Private Wealth first reported a position in Equifax in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Equifax position peaked at $6.11M in Q3 2024.
  • 838 funds tracked by Wall St. Rank held Equifax as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.